BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Oct 27, 2026; 18(10): 121503
Published online Oct 27, 2026. doi: 10.4240/wjgs.121503
Table 1 Comparison of baseline data and clinical characteristics between the two groups
Characteristic
Very high-risk group (n = 35)
Non-very high-risk group (n = 123)
Statistic
P value
Age (year)63 (55-70)60 (52-67)Z = -1.3260.185
Sex (male)21 (60.0)66 (53.7)χ2 = 0.5560.456
BMI (kg/m2)22.8 (20.5-24.9)23.7 (21.5-26.0)Z = -1.5120.131
Abdominal pain/discomfort22 (62.9)63 (51.2)χ2 = 1.6650.197
Gastrointestinal bleeding13 (37.1)29 (23.6)χ2 = 2.7720.096
Palpable abdominal mass9 (25.7)9 (7.3)χ2 = 9.8120.002
Asymptomatic (incidentally detected)5 (14.3)40 (32.5)χ2 = 4.7140.030
Hemoglobin (g/L)112 (98-126)128 (115-140)Z = -3.845< 0.001
Platelet count (× 109/L)240 (195-298)208 (175-255)Z = -2.5010.012
Neutrophil count (× 109/L)5.8 (4.6-7.1)4.4 (3.7-5.3)Z = -4.116< 0.001
Lymphocyte count (× 109/L)1.7 (1.3-2.0)2.1 (1.7-2.5)Z = -3.782< 0.001
NLR3.1 (2.3-4.5)2.1 (1.6-2.8)Z = -4.892< 0.001
Albumin (g/L)38.0 (35.1-40.5)40.8 (38.0-43.5)Z = -3.1240.002
Tumor locationχ2 = 23.453< 0.001
    Stomach12 (34.3)90 (73.2)
    Small intestine18 (51.4)30 (24.4)
    Colorectum and others5 (14.3)3 (2.4)
Tumor rupture7 (20.0)0 (0.0)Fisher’s exact test< 0.001
Mitotic count (> 5/50 HPF)31 (88.6)10 (8.1)χ2 = 95.321< 0.001
Ki-67 index (%)15 (10-25)3 (2-5)Z = -9.123< 0.001


Write to the Help Desk